David is the Founder and Managing Director of Cadarn Capital. He is responsible for promoting our Fund Partners to investors.
David was previously a Partner at the Alternative Investment Fund Manager, Frostrow Capital LLP. He was responsible for the distribution of 12 listed funds with assets of c.£18bn, including Pershing Square Holdings, Ltd., Finsbury Growth & Income Trust PLC, Worldwide Healthcare Trust PLC and The Biotech Growth Trust PLC, having grown the stable from 3 listed funds in 2013.
David has worked across a broad range of investment strategies, in each case working to successfully grow listed fund partners, narrow discounts and/or maintain premium market ratings. He has worked on 4 IPOs and has helped raise c. £1.6bn in the secondary market primarily via regular tap issuance since 2013.
Prior to Frostrow, David worked at Morgan Stanley in the Institutional Sales and Trading Senior Relationship Management (SRM) team covering institutional pension, insurance, asset management and hedge fund clients.
David graduated from King’s College London with a BA (Hons) Degree in History and an MA in Intelligence & International Security. After university, he commissioned into the British Army with the Welsh Guards and completed an operational tour of Afghanistan. David holds the Chartered Alternative Investment Analyst (CAIA) qualification, the Investment Management Certificate (IMC) and the Certificate in Investor Relations (CIR).
He is a Trustee of the Mark Evison Foundation.
It is the responsibility of the individual user to consider his or her legal and regulatory position in the relevant jurisdiction, the risks associated with trading such products and to ensure that the use of the content and the subsequent making of any investment does not contravene any such restrictions or applicable laws and regulations of any jurisdiction. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific security, index, report, opinion, advice or other content. This does not exclude or restrict any duty or liability that Cadarn Capital Ltd has to its clients under the Financial Services and Markets Act 2000 (as amended from time to time) or any other regulatory system under the laws of applicable jurisdictions.
Cadarn Capital Ltd, its subsidiaries, associated entities, partners, employees, representatives or suppliers will not be liable, on any grounds whatsoever, contractually or not, for any direct or indirect damage that may arise as the result of it being possible or impossible to gain access to this site, the accessing, visiting or use of this site and/or the information provided, the sending, or receiving of information via this site and/or the operation or non-operation of this site, except in the event of intentional or serious blame on its part. The information contained on this site, including any third party data is published in good faith and Cadarn Capital Ltd believes that the information is accurate at the time of publication but no representation or warranty, express or implied, is made by Cadarn Capital Ltd as to its accuracy or completeness and it should not be relied on as such.
Cadarn Capital Ltd shall therefore have no liability, save for any liability that Cadarn Capital Ltd may have under the UK Financial Services and Markets Act 2000, for any loss or damage arising out of the use or reliance on the information provided including without limitation, any loss of profit or any other damage, direct or consequential. Nor will Cadarn Capital Ltd, its subsidiaries, associated entities, partners, employees, representatives or suppliers be, under any circumstances, liable for any corruption of data that may occur as the result of technical problems (e.g. transmission errors, technical failures, breakdowns, intervention of third parties, etc.) and/or for any damage or loss relating to software or hardware that is the result of any virus, defect or malfunction in relation to access or use of the site.
Cadarn Capital Ltd is directed at persons who fall within the definition of ‘professional clients’ or ‘eligible counterparties’ as defined in the rules of the Financial Conduct Authority (“FCA”) of the United Kingdom.
The information on this website is provided for information only and does not constitute, and should not be construed as, tax, financial, investment, or legal advice given by the Cadarn Capital to any party; and it is not an offer, contract, guarantee, or solicitation for the purchase or sale of any financial or investment product.
I certify that I am not a US person. Cadarn Capital Ltd is not registered as an investment advisor with the SEC and therefore this document is neither directed at nor intended for US investors.